By Professor Don Edward Smith

Journal articles

Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, 14, pp. 2406 - 2407

Kaufmann GR; Bloch M; Zaunders J; Smith DE; Cooper DA, 2000, 'Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy', AIDS, 14, pp. 959 - 969

Hales GP; Roth N; Smith DE, 2000, 'Possible fatal interaction between protease inhibitors and methamphetamine (letter)', Antiviral Therapy, pp. 19

Correll PK; Smith DE; Grulich AE, 2000, 'Post exposure prophylaxis for non-occupational exposure to HIV: Experience in New South Wales one year after the guidelines', NSW Public Health Bulletin, 11, pp. 114 - 117

Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551

Smith DE; Berrey M; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber RO; Corey L; Cooper DA, 2000, 'Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, 182, pp. 950 - 954

Smith DE, 2000, 'Why does treatment fail?', Journal of Hiv Therapy, pp. 27 - 29

Reijers MH; Weverling GJ; Jurriaans S; Smith DE, 1999, 'Dual maintenance therapy did not sustain suppression of viral replication in HIV-1 infection compared with prolonged reduction therapy', Enfermedades Infecciosas y Microbiologia, 19, pp. 217 - 218

Smith DE; Midgley J; Gazzard B, 1999, 'A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection', International Journal of Clinical Practice, pp. 349 - 352

Mills G; Morgan J; Hales GP; Smith DE, 1999, 'Acute hypersensitivity with delavirdine', Antiviral Therapy, 4, pp. 51 - (letter)

Easterbrook PJ; Goodall RL; Babiker AG; Yu L; Smith DE; Cooper DA; Gazzard B, 1999, 'Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?', Journal of Antimicrobial Chemotherapy, pp. 379 - 388

Smith DE, 1999, 'Dual maintenance therapy did not sustain suppression of viral replication in HIV-1 infection compared with prolonged reduction therapy. Commentary', ACP Journal Club, pp. 14

Smith DE, 1999, 'HIV Trialists Collaborative Group. Zidovudine, didanosine and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence.', Lancet, pp. 2014 - 2025

Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, 180, pp. 320 - 329

Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DE, 1999, 'The use of human immunodeficiency virus post exposure prophylaxis after success-ful artificial insemination.', American Journal of Obstetrics and Gynecology, 181, pp. 760 - 761

Benson EM; Clarkson J; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Stewart GA; Cooper DA; French FA, 1999, 'Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific CTL activity in asymptomatic HIV infected individuals.', AIDS Research and Human Retroviruses, 15, pp. 105 - 113

Law MG; Anderson JS; Cui JS; Duncombe CJ; Mallal SS; Roth N; Fagan D; Smith DE; Bloch M; Grulich AE, 1999, 'Trends in antiretroviral treatment for people with HIV in Australia: an observational database pilot study', Venereology - the Interdisciplinary International Journal of Sexual Health, 12, pp. 97 - 103

Smith D, 1998, 'New approaches in the treatment of HIV infection', Australian Prescriber, 21, pp. 44 - 46, http://dx.doi.org/10.18773/austprescr.1998.033

Montaner JS; Reiss P; Cooper DA; Vella S; Harris MF; Conway B; Wainberg MA; Smith DE; Robinson P; Hall D; Myers MA; Lange JM, 1998, 'A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients', Journal of the American Medical Association, pp. 930 - 937

Smith DE, 1998, 'Compliance and toxicity concerns with antiretroviral therapy.', Journal of Hiv Therapy, pp. 55 - 57

Aboulker J; Babiker AG; Clumeck N; Cooper DA; Darbyshire JH; Dormont J; Gatell J; Goebel F; Laurian Y; Mannucci P; Mathiesen L; Peto TE; Reiss P; Sandstrom E; Savidge G; Seligmann M; Smith DE; Stingl G; Veenstra J; Weller IV; Yeo J; Lafon E; Mccormack S; Swart AM; Withnall R; Duff C; Brodnicki E; Hudson FE; Johnson D; Kelleher PW; Nunn AJ; Evens CD; Phillips S; Fagan D; Tompkinson E; Elia S; D Argoeuves H; Lhoro S; Saioi Y, 1998, 'Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection', AIDS, 12, pp. 1259 - 1265

Smith DE, 1998, 'New approaches in the treatment.', Australian Prescriber, pp. 44 - 46

Kelleher AD; Roggensack M; Jaramillo AB; Smith DE; Walker AC; Gow I; Mcmurchie M; Harris JA; Patou G; Cooper DA; Duncombe CJ; Bloch M; Quan D; Beveridge A; Genn B; Pethebridge A; Todhunter L; Baker D; Mcfarlane R; Mindel A; Knox J; O Connor C; Mitchell JR; Meese P; Chenworth I; Anderson JS; Roth N, 1998, 'Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects', AIDS, 12, pp. 175 - 182

Smith DE, 1997, 'CAESAR coordinating committee (D. Smith, member): Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial', Lancet, pp. 1412 - 1421

Smith DE, 1997, 'Fourth conference on retroviruses and opportunistic infections - Washington DC.', Journal of HIV Combination Therapy, 2, pp. 38 - 40

Antunes F; Atkinson M; Clark AW; Clumeck N; Collis P; Cooper DA; Gazzard B; Gerstoft J; Goh L; Hill AH; Katlama C; Korsia S; Lange JM; Mccallum L; Mcdade H; Montaner JS; Moroni M; Norkrans G; Opravil M; Reiss P; Rozenbaum W; Scott JH; Smith DE; Staszewski S; Stoffels P, 1997, 'Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.', Lancet, pp. 1413 - 1421

Clezy KR; Smith DE; Cooper DA, 1997, 'Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimes for patients with HIV-1 infection: the CAESAR trial', Lancet, pp. 1414 - 1421

Smith DE, 1997, 'Why treat primary HIV infection?', Journal of HIV Combination Therapy, pp. 41 - 43

Moyle GJ; Bouza E; Antunes F; Smith DE; Harris RI; Warburg M; Walker M, 1997, 'Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3 : a double blind controlled trial.', Antiviral Therapy, 2, pp. 229 - 236

Workman C; Downie J; Smith DE; Sutherland D; Michelmore H; Dyer W; Shen J; Sullivan J, 1996, 'Combination therapies in primary HIV infection', AIDS, 10, pp. OP11 - OP11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Smith DE; Cooper DA; Walker A; Gow I; Patou G, 1996, 'Effect of therapeutic vaccination (p24-VLP) and AZT on immunological markers in early HIV disease', AIDS, 10, pp. P137 - P137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith DE; Boag F; Colebunders R; Weller IVD; Tchamouroff S; Weber J; Gow I; Patou G; Cooper DA, 1996, 'Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection does not alter CD4 decline', AIDS, 10, pp. OP65 - OP65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith DE, 1996, 'What can we learn from Delta?', HIV Journal Club, pp. 66 - 66

SMITH DE, 1994, 'EFFICIENT DIAGNOSIS OF PNEUMOCYSTIS-CARINII PNEUMONIA', INTERNATIONAL JOURNAL OF STD & AIDS, 5, pp. 1 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NE81000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anderson I; Beveridge A; Hales G; Smith D, 1994, 'Intensive Phase II Therapeutie HIV Vaccine Trials Can Be Appropriately Conducted Through Community Networks', AIDS, 8, pp. S48 - S48, http://dx.doi.org/10.1097/00002030-199411004-00185

Nelson MR; Smith D; Erskine D; Gazzard BG, 1993, 'Ventricular fibrillation secondary to itraconazole induced hypokalaemia.', J Infect, 26, pp. 348, http://dx.doi.org/10.1016/0163-4453(93)96203-3

Smith D; Erskine D; Steele J; Hills D; Gazzard B, 1992, 'Comparison of nebuliser efficiency for aerosolizing pentamidine.', J Pharm Pharmacol, 44, pp. 7 - 9, http://dx.doi.org/10.1111/j.2042-7158.1992.tb14353.x

Smith DE; Forbes A; Davies S; Barton SE; Gazzard BG, 1992, 'Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments.', Thorax, 47, pp. 1005 - 1009, http://dx.doi.org/10.1136/thx.47.12.1005

Smith DE; Davies S; Smithson J; Harding I; Gazzard BG, 1992, 'Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients.', AIDS, 6, pp. 1489 - 1493, http://dx.doi.org/10.1097/00002030-199212000-00011

Smith DE; Hills DA; Gazzard BG, 1992, 'Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia.', AIDS, 6, pp. 1044 - 1045, http://dx.doi.org/10.1097/00002030-199209000-00024

Smith D; van de Velde V; Woestenborghs R; Gazzard BG, 1992, 'The pharmacokinetics of oral itraconazole in AIDS patients.', J Pharm Pharmacol, 44, pp. 618 - 619, http://dx.doi.org/10.1111/j.2042-7158.1992.tb05478.x

Kell PD; Barton SE; Smith DE; Nelson M; Marwood RP; Gazzard B, 1991, 'A maternal death caused by AIDS. Case report.', Br J Obstet Gynaecol, 98, pp. 725 - 727, http://dx.doi.org/10.1111/j.1471-0528.1991.tb13465.x

Kell PD; Smith DE; Barton SE; Midgley J; Samarasinghe PL; Gazzard BG, 1991, 'Disseminated histoplasmosis in an AIDS patient treated with itraconazole.', Genitourin Med, 67, pp. 342 - 344, http://dx.doi.org/10.1136/sti.67.4.342

Smith DE; Kell P; Hills DA; Hawkins DA; Gazzard BG, 1991, 'Domiciliary nebulized pentamidine prophylaxis.', Int J STD AIDS, 2, pp. 215 - 216, http://dx.doi.org/10.1177/095646249100200318

Smith D; Boag F; Midgley J; Gazzard B, 1991, 'Fluconazole resistant candida in AIDS.', J Infect, 23, pp. 345 - 346, http://dx.doi.org/10.1016/0163-4453(91)93584-y

Smith DE; Midgley J; Allan M; Connolly GM; Gazzard BG, 1991, 'Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.', AIDS, 5, pp. 1367 - 1371, http://dx.doi.org/10.1097/00002030-199111000-00014

, 1991, 'Nebulized Pentamidine for the Prevention of <italic>Pneumocystis carinii</italic> Pneumonia in AIDS Patients: Experience of 173 Patients and a Review of the Literature', QJM: An International Journal of Medicine, http://dx.doi.org/10.1093/oxfordjournals.qjmed.a068613

Smith D; Gazzard B, 1991, 'Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients.', Drugs, 42, pp. 628 - 639, http://dx.doi.org/10.2165/00003495-199142040-00006

Nelson M; Bower M; Smith D; Gazzard BG, 1990, 'Life-threatening complication of sputum induction.', Lancet, 335, pp. 112 - 113, http://dx.doi.org/10.1016/0140-6736(90)90580-x

Smith D; Davies S; Nelson M; Youle M; Gleeson J; Gazzard B, 1990, 'Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.', AIDS, 4, pp. 1019 - 1021, http://dx.doi.org/10.1097/00002030-199010000-00012

Back to profile page